NEXENTIS TECHNOLOGIES INC. Equity Method Investment, Ownership Percentage
NEXENTIS TECHNOLOGIES INC. (NXTS) had Equity Method Investment, Ownership Percentage of 98.48% as of 2009-04-27, per its 10-Q filed 2022-05-16.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2022-05-16
- 2009-04-27: Equity Method Investment, Ownership Percentage 98.48%; Equity Method Investment, Ownership Percentage as first filed 98.94%.
| Period end | Equity Method Investment, Ownership Percentage | Equity Method Investment, Ownership Percentage as first filed |
|---|---|---|
| 2009-04-27 | 98.48% 10-Q · filed 2022-05-16 | 98.94% 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |